Literature DB >> 30869791

High-Density Lipoprotein Cholesterol and All-Cause and Cause-Specific Mortality Among the Elderly.

Zhi-Hao Li1, Yue-Bin Lv2, Wen-Fang Zhong1, Xiang Gao3, Virginia Byers Kraus4, Meng-Chen Zou5, Xi-Ru Zhang1, Fu-Rong Li1, Jin-Qiu Yuan6, Xiao-Ming Shi2, Xian-Bo Wu1, Chen Mao1.   

Abstract

CONTEXT: The patterns of the association between high-density lipoprotein cholesterol (HDL-C) concentrations and mortality among the elderly are still unclear.
OBJECTIVE: To examine the association of HDL-C concentrations with mortality and to identify the optimal HDL-C concentration range that predicts the lowest risk of all-cause mortality among the elderly.
DESIGN: This was a nationwide, community-based, prospective cohort study. PARTICIPANTS: This study included 7766 elderly individuals (aged ≥65 years; mean age: 74.4 years) from the Health and Retirement Study. Cox proportional hazards models and Cox models with penalized smoothing splines were used to estimate hazard ratios (HRs) with 95% CI for all-cause and cause-specific mortality.
RESULTS: During a median follow-up of 5.9 years, 1921 deaths occurred. After a full adjustment for covariates, a nonlinear (P < 0.001 for nonlinearity) association was found between HDL-C and all-cause mortality [minimum mortality risk at 71 mg/dL (1.84 mM)]; the risk for all-cause mortality was significantly higher in the groups with HDL-C concentration <61 mg/dL (1.58 mM; HR: 1.18; 95% CI: 1.05 to 1.33) and with HDL-C concentration >87 mg/dL (2.25 mM; HR: 1.56; 95% CI: 1.17 to 2.07) than in the group with HDL-C concentrations ranging from 61 to 87 mg/dL (1.58 to 2.25 mM). Nonlinear associations of HDL-C concentrations with both cardiovascular and noncardiovascular mortality were also observed (both P < 0.001 for nonlinearity).
CONCLUSIONS: Among the elderly, nonlinear associations were found between HDL-C and all-cause and cardiovascular mortality. The single optimal HDL-C concentration and range were 71 mg/dL and 61 to 87 mg/dL, respectively.
Copyright © 2019 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30869791     DOI: 10.1210/jc.2018-02511

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  A Novel Cell-Free Fluorescent Assay for HDL Function: Low Apolipoprotein A1 Exchange Rate Associated with Increased Incident Cardiovascular Events.

Authors:  Shuhui Wang Lorkowski; Gregory Brubaker; Lin Li; Xinmin S Li; Stanley L Hazen; Jonathan D Smith
Journal:  J Appl Lab Med       Date:  2020-05-01

2.  A dose-response meta-analysis to evaluate the relationship between high-density lipoprotein cholesterol and all-cause and cardiovascular disease mortality.

Authors:  L Liu; M Han; R Qie; Q Li; X Zhang; J Zhang; S Zhan; L Zhang; Z Xu; C Zhang; F Hong
Journal:  J Endocrinol Invest       Date:  2021-10-21       Impact factor: 4.256

3.  U-Shaped Association of High-Density Lipoprotein Cholesterol with All-Cause and Cardiovascular Mortality in Hypertensive Population.

Authors:  Chao-Lei Chen; Xiao-Cong Liu; Lin Liu; Kenneth Lo; Yu-Ling Yu; Jia-Yi Huang; Yu-Qing Huang; Ji-Yan Chen
Journal:  Risk Manag Healthc Policy       Date:  2020-10-08

4.  Investigation of the Reference Interval Values of Fasting Plasma Glucose, Blood Pressure, and Blood Lipids in the Longevity People Aged 90 Years Old and Above.

Authors:  Zhaoping Wang; Xiaolin Ni; Danni Gao; Liang Sun; Xiaoquan Zhu; Juan Jiao; Qi Zhou; Chen Chen; Nan Zhang; Zhu Wu; Ze Yang; Huiping Yuan
Journal:  Diabetes Metab Syndr Obes       Date:  2021-08-21       Impact factor: 3.168

5.  Associations of plasma high-sensitivity C-reactive protein concentrations with all-cause and cause-specific mortality among middle-aged and elderly individuals.

Authors:  Zhi-Hao Li; Wen-Fang Zhong; Yue-Bin Lv; Virginia Byers Kraus; Xiang Gao; Pei-Liang Chen; Qing-Mei Huang; Jin-Dong Ni; Xiao-Ming Shi; Chen Mao; Xian-Bo Wu
Journal:  Immun Ageing       Date:  2019-11-05       Impact factor: 6.400

6.  The U Shaped Relationship Between High-Density Lipoprotein Cholesterol and All-Cause or Cause-Specific Mortality in Adult Population.

Authors:  Yu-Qing Huang; Xiao-Cong Liu; Kenneth Lo; Lin Liu; Yu-Ling Yu; Chao-Lei Chen; Jia-Yi Huang; Ying-Qing Feng; Bin Zhang
Journal:  Clin Interv Aging       Date:  2020-10-02       Impact factor: 4.458

7.  Prognostic Role of Neutrophil to High-Density Lipoprotein Cholesterol Ratio for All-Cause and Cardiovascular Mortality in the General Population.

Authors:  Ming Jiang; Jinyu Sun; Huayiyang Zou; Menghuan Li; Zhenyang Su; Wei Sun; Xiangqing Kong
Journal:  Front Cardiovasc Med       Date:  2022-02-08

8.  Monocyte-to-high-density lipoprotein-cholesterol ratio (MHR) and the risk of all-cause and cardiovascular mortality: a nationwide cohort study in the United States.

Authors:  Ming Jiang; Jiaming Yang; Huayiyang Zou; Menghuan Li; Wei Sun; Xiangqing Kong
Journal:  Lipids Health Dis       Date:  2022-03-18       Impact factor: 3.876

9.  Is HDL cholesterol protective in patients with type 2 diabetes? A retrospective population-based cohort study.

Authors:  Giovanni Fanni; Rosalba Rosato; Luigi Gentile; Matteo Anselmino; Simone Frea; Valentina Ponzo; Marianna Pellegrini; Fabio Broglio; Francesca Pivari; Gaetano Maria De Ferrari; Ezio Ghigo; Simona Bo
Journal:  J Transl Med       Date:  2020-05-06       Impact factor: 5.531

Review 10.  HDL Is Not Dead Yet.

Authors:  Shuhui Wang Lorkowski; Jonathan D Smith
Journal:  Biomedicines       Date:  2022-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.